Open Market Insiders Trades - Buys only
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- P - Open market or private purchase of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
CRD-B
|
Harshavardhan V Agadi
Director |
BUY
Open market or private purchase
|
Indirect | 500 Added 0.93% |
$4,725
$9.45 p/Share
|
Mar 17
2021 |
RMBL
|
Adam Alexander
Director |
BUY
Open market or private purchase
|
Direct | 1,000 Added 10.47% |
$57,330
$57.33 p/Share
|
Mar 17
2021 |
SCOR
|
William Paul Livek
Director |
BUY
Open market or private purchase
|
Direct | 116,987 Added 11.38% |
$422,323
$3.61 p/Share
|
Mar 17
2021 |
SELB
|
Peter G Traber
Chief Medical Officer |
BUY
Open market or private purchase
|
Direct | 10,000 Added 10.2% |
$45,300
$4.53 p/Share
|
Mar 17
2021 |
FXNC
|
Gerald F Smith Jr
Director |
BUY
Open market or private purchase
|
Direct | 2,631 Added 8.74% |
$47,726
$18.14 p/Share
|
Mar 17
2021 |
HSON
|
Jeffrey E. Eberwein
Chief Executive Officer |
BUY
Open market or private purchase
|
Direct | 500 Added 0.42% |
$8,400
$16.8 p/Share
|
Mar 17
2021 |
LVO
|
Robert S Ellin
CEO & Chairman |
BUY
Open market or private purchase
|
Direct | 3,000 Added 0.19% |
$13,800
$4.6 p/Share
|
Mar 17
2021 |
UIHC
|
Alec Poitevint Ii
Director |
BUY
Open market or private purchase
|
Indirect | 25,000 Added 2.27% |
$187,250
$7.49 p/Share
|
Mar 17
2021 |
OPTN
|
Peter K Miller
Chief Executive Officer |
BUY
Open market or private purchase
|
Direct | 787 Added 0.13% |
$3,030
$3.85 p/Share
|
Mar 17
2021 |
ADEX-UN
|
Eric L Munson
Director |
BUY
Open market or private purchase
|
Direct | 500 Added 50.0% |
-
|
Mar 17
2021 |
DSE
|
Css LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 1,967 Added 0.46% |
$14,752
$7.5 p/Share
|
Mar 17
2021 |
JAKK
|
Lawrence I Rosen
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 16,227 Added 2.5% |
$139,227
$8.58 p/Share
|
Mar 17
2021 |
HAYW
|
Rick Roetken
President, North America |
BUY
Open market or private purchase
|
Direct | 1,500 Added 2.97% |
$25,500
$17.0 p/Share
|
Mar 16
2021 |
HAYW
|
Lawrence Harris Silber
Director |
BUY
Open market or private purchase
|
Direct | 10,000 Added 36.56% |
$170,000
$17.0 p/Share
|
Mar 16
2021 |
HAYW
|
Michael Colicchio
VP and Corporate Controller |
BUY
Open market or private purchase
|
Direct | 1,500 Added 1.3% |
$25,500
$17.0 p/Share
|
Mar 16
2021 |
HAYW
|
Eifion Jones
Senior Vice President and CFO |
BUY
Open market or private purchase
|
Direct | 6,500 Added 50.0% |
$110,500
$17.0 p/Share
|
Mar 16
2021 |
HAYW
|
Arthur L Soucy
Director |
BUY
Open market or private purchase
|
Direct | 5,550 Added 7.13% |
$94,350
$17.0 p/Share
|
Mar 16
2021 |
HAYW
|
Kevin Holleran
President and CEO |
BUY
Open market or private purchase
|
Direct | 8,000 Added 1.71% |
$136,000
$17.0 p/Share
|
Mar 16
2021 |
HAYW
|
Lori A Walker
Director |
BUY
Open market or private purchase
|
Direct | 2,000 Added 17.62% |
$34,000
$17.0 p/Share
|
Mar 16
2021 |
PFSI
|
Mfn Partners, LP
Director |
BUY
Open market or private purchase
|
Direct | 70,668 Added 17.26% |
$4,608,260
$65.21 p/Share
|
Mar 16
2021 |
CPPTL
|
Silver Point Capital L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 79,065 Added 0.65% |
$1,446,889
$18.3 p/Share
|
Mar 16
2021 |
FEIM
|
Edenbrook Capital, LLC
Director |
BUY
Open market or private purchase
|
Indirect | 408 Added 0.03% |
$4,810
$11.79 p/Share
|
Mar 16
2021 |
PFSI
|
Farhad Nanji
Director |
BUY
Open market or private purchase
|
Indirect | 70,668 Added 12.19% |
$4,608,260
$65.21 p/Share
|
Mar 16
2021 |
HSON
|
Jeffrey E. Eberwein
Chief Executive Officer |
BUY
Open market or private purchase
|
Direct | 500 Added 0.43% |
$8,290
$16.58 p/Share
|
Mar 16
2021 |
NYC
|
Edward M Weil Jr.
Director |
BUY
Open market or private purchase
|
Direct | 150 Added 1.38% |
$1,338
$8.92 p/Share
|
Mar 16
2021 |
RXDX
|
Perceptive Advisors LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 850,000 Added 20.41% |
$16,150,000
$19.0 p/Share
|
Mar 16
2021 |
RXDX
|
Rtw Investments, LP
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 800,000 Added 50.0% |
$15,200,000
$19.0 p/Share
|
Mar 16
2021 |
VICI
|
James R Abrahamson
Director |
BUY
Open market or private purchase
|
Direct | 13,200 Added 10.3% |
$373,032
$28.26 p/Share
|
Mar 16
2021 |
RXDX
|
Mark Stenhouse
Chief Operating Officer |
BUY
Open market or private purchase
|
Direct | 14,000 Added 50.0% |
$266,000
$19.0 p/Share
|
Mar 16
2021 |
RXDX
|
Joseph C Papa
Director |
BUY
Open market or private purchase
|
Direct | 15,000 Added 50.0% |
$285,000
$19.0 p/Share
|
Mar 16
2021 |
RXDX
|
Helen C. Adams
Director |
BUY
Open market or private purchase
|
Direct | 500 Added 50.0% |
$9,500
$19.0 p/Share
|
Mar 16
2021 |
AATC
|
Joseph Patrick Daly
Director |
BUY
Open market or private purchase
|
Direct | 1,107 Added 1.18% |
$5,236
$4.73 p/Share
|
Mar 16
2021 |
FORA
|
Stanley S Trotman Jr |
BUY
Open market or private purchase
|
Direct | 4,067 Added 7.16% |
$49,658
$12.21 p/Share
|
Mar 16
2021 |
VATE
|
Wayne Barr Jr
President and CEO |
BUY
Open market or private purchase
|
Direct | 6,000 Added 2.22% |
$21,900
$3.65 p/Share
|
Mar 16
2021 |
ORCL
|
Rona Alison Fairhead
Director |
BUY
Open market or private purchase
|
Direct | 2,530 Added 23.04% |
$172,040
$68.0 p/Share
|
Mar 16
2021 |
ORCL
|
Rona Alison Fairhead
Director |
BUY
Open market or private purchase
|
Indirect | 7,712 Added 50.0% |
$516,935
$67.03 p/Share
|
Mar 16
2021 |
TPL
|
Murray Stahl
Director |
BUY
Open market or private purchase
|
Indirect | 30 Added 0.17% |
$46,612
$1553.72 p/Share
|
Mar 16
2021 |
TPL
|
Murray Stahl
Director |
BUY
Open market or private purchase
|
Direct | 3 Added 0.25% |
$4,661
$1553.72 p/Share
|
Mar 16
2021 |
RXDX
|
Point72 Biotech Private Investments, LLC |
BUY
Open market or private purchase
|
Indirect | 800,000 Added 23.2% |
$15,200,000
$19.0 p/Share
|
Mar 16
2021 |
RCG
|
Murray Stahl
President and CEO |
BUY
Open market or private purchase
|
Indirect | 675 Added 0.19% |
$1,843
$2.73 p/Share
|
Mar 16
2021 |
LGIH
|
Duncan S Gage
Director |
BUY
Open market or private purchase
|
Direct | 697 Added 2.37% |
$95,886
$137.57 p/Share
|
Mar 16
2021 |
MGPI
|
Brandon Gall
Interim President & CEO; CFO |
BUY
Open market or private purchase
|
Direct | 19 Added 0.09% |
$1,231
$64.77 p/Share
|
Mar 16
2021 |
HTLF
|
Christopher Hylen
Director |
BUY
Open market or private purchase
|
Direct | 3,500 Added 50.0% |
$98,210
$28.06 p/Share
|
Mar 16
2021 |
CODI
|
Ryan J Faulkingham |
BUY
Open market or private purchase
|
Direct | 4,000 Added 17.09% |
$94,440
$23.61 p/Share
|
Mar 16
2021 |
MYE
|
Jeffrey Kramer |
BUY
Open market or private purchase
|
Direct | 10,000 Added 50.0% |
$198,200
$19.82 p/Share
|
Mar 16
2021 |
MYE
|
Ronald M Defeo |
BUY
Open market or private purchase
|
Direct | 10,000 Added 21.81% |
$198,000
$19.8 p/Share
|
Mar 16
2021 |
PLMIU
|
Alok Sama
Director |
BUY
Open market or private purchase
|
Indirect | 300,000 Added 50.0% |
$3,000,000
$10.0 p/Share
|
Mar 16
2021 |
TIPT
|
Arif Inayatullah
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 40,000 Added 1.31% |
$304,000
$7.6 p/Share
|
Mar 16
2021 |
TIPT
|
Jonathan Ilany
Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect | 5,000 Added 5.62% |
$37,000
$7.4 p/Share
|
Mar 16
2021 |
TIPT
|
Paul M Friedman
Director |
BUY
Open market or private purchase
|
Direct | 20,000 Added 20.77% |
$155,800
$7.79 p/Share
|
Mar 16
2021 |